We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

A new clinical trial presented at the 2024 American Society for Nutrition Annual Meeting evaluated the effects of 100 milligrams of Boswellia serrata extract on joint comfort, inflammation, functional ...

For example, a 2001 study found that B. serrata extract wasn’t inferior to mesalazine (a nonsteroidal anti-inflammatory drug) in treating active Crohn’s disease. However, a 2011 study found ...

AKBA opened at $1.93 on Thursday. Akebia Therapeutics has a one year low of $0.80 and a one year high of $2.48. The business has a 50 day simple moving average of $1.91 and a two-hundred day ...

Akebia Therapeutics (NASDAQ:AKBA – Get Free Report) was downgraded by stock analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and ...

Analyst Ed Arce of H.C. Wainwright maintained a Buy rating on Akebia Therapeutics (AKBA – Research Report), retaining the price target of $7.50. Discover outperforming stocks and invest smarter ...

Akebia (AKBA) Therapeutics announced multiple positive business updates. As of January, Vafseo tablets are available in the U.S. for adult patients with anemia due to chronic kidney disease on ...